Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2276.55 and 2320.55
| Intraday Target 1 | 2268.7 |
| Intraday Target 2 | 2284.4 |
| Intraday Target 3 | 2312.7 |
| Intraday Target 4 | 2328.4 |
| Intraday Target 5 | 2356.7 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 25 May 2026 | 2300.10 (-0.29%) | 2329.00 | 2297.00 - 2341.00 | 1.168 times | Fri 22 May 2026 | 2306.90 (-0.59%) | 2330.00 | 2297.00 - 2344.00 | 1.9409 times | Thu 21 May 2026 | 2320.70 (-1.11%) | 2379.00 | 2314.00 - 2379.20 | 1.1139 times | Wed 20 May 2026 | 2346.80 (-1.78%) | 2388.00 | 2340.10 - 2397.80 | 0.8401 times | Tue 19 May 2026 | 2389.40 (-0.02%) | 2400.00 | 2377.20 - 2422.60 | 0.8063 times | Mon 18 May 2026 | 2389.80 (-2.01%) | 2438.80 | 2370.00 - 2440.00 | 0.734 times | Fri 15 May 2026 | 2438.80 (0.91%) | 2418.00 | 2407.40 - 2458.60 | 0.4683 times | Thu 14 May 2026 | 2416.70 (0.21%) | 2437.10 | 2400.00 - 2466.20 | 0.6027 times | Wed 13 May 2026 | 2411.70 (-1.52%) | 2449.90 | 2400.40 - 2520.00 | 1.4445 times | Tue 12 May 2026 | 2448.80 (0.52%) | 2436.20 | 2407.40 - 2493.70 | 0.8812 times | Mon 11 May 2026 | 2436.20 (-1.64%) | 2476.90 | 2430.50 - 2476.90 | 0.3339 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2276.55 and 2320.55
| Weekly Target 1 | 2268.7 |
| Weekly Target 2 | 2284.4 |
| Weekly Target 3 | 2312.7 |
| Weekly Target 4 | 2328.4 |
| Weekly Target 5 | 2356.7 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 25 May 2026 | 2300.10 (-0.29%) | 2329.00 | 2297.00 - 2341.00 | 0.3535 times | Fri 22 May 2026 | 2306.90 (-5.41%) | 2438.80 | 2297.00 - 2440.00 | 1.6452 times | Fri 15 May 2026 | 2438.80 (-1.54%) | 2476.90 | 2400.00 - 2520.00 | 1.1292 times | Fri 08 May 2026 | 2476.90 (6.01%) | 2342.00 | 2322.50 - 2504.90 | 1.5399 times | Thu 30 April 2026 | 2336.40 (-5.49%) | 2472.00 | 2319.40 - 2495.00 | 1.4267 times | Fri 24 April 2026 | 2472.00 (0.74%) | 2465.00 | 2397.10 - 2529.90 | 0.7623 times | Fri 17 April 2026 | 2453.90 (2.5%) | 2370.10 | 2341.20 - 2468.80 | 0.6399 times | Fri 10 April 2026 | 2394.00 (3.57%) | 2307.00 | 2267.80 - 2431.80 | 0.7261 times | Thu 02 April 2026 | 2311.50 (2.3%) | 2259.50 | 2217.60 - 2401.90 | 0.98 times | Fri 27 March 2026 | 2259.50 (-5.25%) | 2353.40 | 2255.10 - 2364.90 | 0.7972 times | Fri 20 March 2026 | 2384.80 (-1.63%) | 2413.00 | 2362.50 - 2472.00 | 0.581 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2187.05 and 2410.05
| Monthly Target 1 | 2149.37 |
| Monthly Target 2 | 2224.73 |
| Monthly Target 3 | 2372.3666666667 |
| Monthly Target 4 | 2447.73 |
| Monthly Target 5 | 2595.37 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 25 May 2026 | 2300.10 (-1.55%) | 2342.00 | 2297.00 - 2520.00 | 0.8862 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.783 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.6309 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.9206 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8224 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.344 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.121 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7279 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.1595 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.6046 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.9797 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2007.75 and 2509.95
| Yearly Target 1 | 1910.3 |
| Yearly Target 2 | 2105.2 |
| Yearly Target 3 | 2412.5 |
| Yearly Target 4 | 2607.4 |
| Yearly Target 5 | 2914.7 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 25 May 2026 | 2300.10 (-7.01%) | 2476.00 | 2217.60 - 2719.80 | 0.3716 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6125 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2211 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2347 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7171 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9566 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0675 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4567 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2323 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1299 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1302 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
And this trend seems to be continuing further.Price is below an important level of 2366.76 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 30 as on Mon 25 May 2026
This Munafa value indicates that the stock is moving downwards and might continue to move down.
SMA20 is at 2393 and price is deviating by 54 points
Upper Bollinger band is at 2499 and lower is at 2287, while middle bands are at 2340 and 2446
Price is coming down
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and the sell signal is strong.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2364.17 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2332.78 |
| 12 day DMA | 2390.23 |
| 20 day DMA | 2392.67 |
| 35 day DMA | 2398.16 |
| 50 day DMA | 2393.01 |
| 100 day DMA | 2434.72 |
| 150 day DMA | 2484.13 |
| 200 day DMA | 2555.6 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2330.57 | 2345.8 | 2365.24 |
| 12 day EMA | 2366.76 | 2378.87 | 2391.95 |
| 20 day EMA | 2383.26 | 2392.01 | 2400.96 |
| 35 day EMA | 2392.49 | 2397.93 | 2403.29 |
| 50 day EMA | 2396.04 | 2399.95 | 2403.75 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2332.78 | 2350.72 | 2377.1 |
| 12 day SMA | 2390.23 | 2405.33 | 2415.03 |
| 20 day SMA | 2392.67 | 2401.27 | 2410.65 |
| 35 day SMA | 2398.16 | 2398.99 | 2398.31 |
| 50 day SMA | 2393.01 | 2397.39 | 2401.6 |
| 100 day SMA | 2434.72 | 2436.59 | 2438.52 |
| 150 day SMA | 2484.13 | 2487.13 | 2490.2 |
| 200 day SMA | 2555.6 | 2560.08 | 2564.3 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 60.27 and PE is: 38.16
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
EPS is 56.39 and PE is: 40.79
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
